Order RSDLImportant Safety Information

ACT WHEN EVERY SECOND COUNTS

DESIGNED FOR EASE OF USE IN HIGH-STRESS SITUATIONS

Trusted by militaries and emergency responders worldwide, RSDL meets FDA Class I Medical Device requirements to deliver rapid, effective decontamination when every second counts1-5,*

Single-use, tear-open packet with presoaked sponge is ready for immediate use1,4,6

  1. Two open bare palms on asphalt

    Identify

    area of possible contamination.

  2. Hands tearing a green RSDL packet open, yellow sponge emerging

    Open

    packet quickly at notch.

  3. Yellow sponge scrubbed across a forearm

    Wipe

    affected area using a scrubbing action. Allow to remain on the skin for at least 2 minutes.

  4. Water running over cupped hands

    Rinse

    as soon as conditions permit.

During emergency situations, RSDL does not require immediate removal from the skin, but it should be rinsed as soon as it is safe to do so.1

*Decontamination data come from studies of animals and ex vivo human skin.7-10

  • FITS ANY KIT11

    Compact and portable

  • STABLE STORAGE1,12

    Between 59°F and 86°F (15°C-30°C)

  • LONG-LASTING RELIABILITY4

    5-year shelf life from the date of manufacture

MILITARY-GRADE PACKAGE

The RSDL packaging has been tested in accordance with US military standard MIL-STD-810, ensuring proven resistance to harsh operational environments.11

EFFECTIVE AND SAFE DECONTAMINATION TRUSTED AROUND THE WORLD

RSDL was developed specifically for use on human skin in high-risk environments and is recognized across the armed forces community4,13

Procured by or registered with2,3,5,13:

  • US FDA
  • US Department of War, Defense Logistics Agency
  • Joint Program Executive Office for Chemical and Biological Defense
  • US Department of State
  • Other military services worldwide since 2002

Certified by13:

  • US Department of Homeland Security, SAFETY Act

Important Safety Information

Intended Use

The RSDL® (Reactive Skin Decontamination Lotion) kit is intended to remove and/or neutralize chemical warfare agents (CWA) and T-2 toxin from the skin. For external use only by trained individuals. Use only if chemical warfare agent exposure is suspected.

CAUTION: Use only as directed. RSDL® is not a substitute for proper protective breathing devices and garments. Not for use prior to exposure (i.e., prophylactic use) or whole-body decontamination. Allow RSDL® to remain on the skin for at least two minutes. An RSDL® ingredient is absorbed through the skin which may cause adverse effects. Avoid leaving on the skin for long periods. Avoid contact with the eyes and mucous membranes and rinse eyes thoroughly if contact occurs. Remove RSDL® with soap and water when conditions permit. Keep out of reach of children.

WARNING: Fire Hazard. Combustion may occur upon contact with strong oxidizing chemicals (e.g., HTH [calcium hypochlorite], Super Tropical Bleach). Do not discard used RSDL® components into strong oxidizing chemicals or their containers.

The SAFETY Act (“the Act”) provides incentives for the development and deployment of anti-terrorism technologies by creating a system of “risk management” and a system of “litigation management.” The purpose of the Act is to ensure that the threat of liability does not deter potential manufacturers or Sellers of anti-terrorism technologies from developing, commercializing, and deploying technologies that could significantly reduce the risks or mitigate the effects of large-scale terrorist events. Thus, the Act creates certain liability limitations for “claims arising out of, relating to or resulting from an Act of Terrorism” where Qualified Anti-Terrorism Technologies have been deployed. The Act does not limit liability for harms caused by anti-terrorism technologies when no Act of Terrorism has occurred.

Suspected Adverse Events, Product Complaints & Medical Information:
serbmedinfo@serb.com / 877-377-3784

For more information on RSDL including order inquiries, please contact:
SERB MEDICAL SOLUTIONS INC. / 300 Four Falls Corporate Center, 300 Conshohocken State Road, Suite 300, West Conshohocken, PA 19428-3820
RSDL@serb.com

References
  1. National Urban Security Technology Laboratory. Personal Decontamination Kits Market Survey Report. US Department of Homeland Security; 2017.
  2. Data on file, REF-3588. SERB Pharmaceuticals.
  3. Data on file, REF-3589. SERB Pharmaceuticals.
  4. Data on file. Reactive Skin Decontamination Lotion Kit. Clinical Evaluation Plan. March 2025. SERB Pharmaceuticals.
  5. Data on file. FDA Regulatory Analysis of Reactive Skin Decontamination Lotion Labeling Changes. November 2025. SERB Pharmaceuticals.
  6. Franken J, Mikler J. Reactive Skin Decontamination Lotion (RSDL) safety with clinical antiseptics and hemostatic agents. Toxicol Lett. 2024;395:11-16.
  7. Schwartz MD, Hurst CG, Kirk MA, Reedy SJD, Braue EH Jr. Reactive Skin Decontamination Lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure. Curr Pharm Biotechnol. 2012;13(10):1971-1979.
  8. Hanssen KA, Doxzon BF, Lumpkin HL, Clarkson E, Braue EH Jr. Evaluation of Decontamination Systems Challenged With Nerve Agents. US Army Medical Research Institute of Chemical Defense, US Department of War; 2006.
  9. Snider TH, Hayes TL, Jarvis RJ II, Matthews MC, Estep JE. A Medical Research and Evaluation Facility (MREF) and Studies Supporting the Medical Chemical Defense Program on Module 1 of Task 0008, Assessment of RSDL as a Decontaminant Against VX and HD: Efficacy, Equivalence to M291 Skin Decontamination Kit, and Compatibility with Fielded Materials. Battelle; 2001.
  10. Thors L, Lindberg S, Johansson S, et al. RSDL decontamination of human skin contaminated with the nerve agent VX. Toxicol Lett. 2017;269:47-54.
  11. Data on file, REF-3590. SERB Pharmaceuticals.
  12. RSDL® (Reactive Skin Decontamination Lotion Kit). Safety Data Sheet. 2025.
  13. Chemical Hazards Emergency Medical Management. Reactive Skin Decontamination Lotion (RSDL) - Medical Countermeasures Database. US Department of Health and Human Services. Accessed June 30, 2026. https://chemm.hhs.gov/countermeasure_RSDL.htm